相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Key chemokines direct migration of immune cells in solid tumors
Karan Kohli et al.
CANCER GENE THERAPY (2022)
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak et al.
CLINICAL CANCER RESEARCH (2021)
Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
Natalia Ochocka et al.
NATURE COMMUNICATIONS (2021)
Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
Thamiris Becker Scheffel et al.
FRONTIERS IN ONCOLOGY (2021)
Role of myeloid cells in the immunosuppressive microenvironment in gliomas
Chiara Locarno et al.
IMMUNOBIOLOGY (2020)
CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2
Caren Yu-Ju Wu et al.
NEURO-ONCOLOGY (2020)
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
John de Groot et al.
NEURO-ONCOLOGY (2020)
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A. Flores-Toro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas
Malgorzata Sielska et al.
BRITISH JOURNAL OF CANCER (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study
Giuseppe Lombardi et al.
CANCERS (2020)
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158
Yvonne Grobben et al.
JOURNAL OF STRUCTURAL BIOLOGY-X (2020)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment
Adela Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma (vol 25, pg 462, 2019)
Junfei Zhao et al.
NATURE MEDICINE (2019)
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Malgorzata Czystowska-Kuzmicz et al.
NATURE COMMUNICATIONS (2019)
Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression
Aya Hirata et al.
CANCER GENE THERAPY (2019)
Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme
Miha Koprivnikar Kranjc et al.
RADIOLOGY AND ONCOLOGY (2019)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
T-cell Dysfunction in Glioblastoma: Applying a New Framework
Karolina I. Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke
David Sacks et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
ARGINASE: A MULTIFACETED ENZYME IMPORTANT IN HEALTH AND DISEASE
R. William Caldwell et al.
PHYSIOLOGICAL REVIEWS (2018)
In Search for Reliable Markers of Glioma-Induced Polarization of Microglia
Kacper A. Walentynowicz et al.
FRONTIERS IN IMMUNOLOGY (2018)
Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells
Yukiyoshi Mita et al.
INTERNATIONAL IMMUNOLOGY (2018)
The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target
King Pan Ng et al.
PLOS ONE (2018)
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E. Kim et al.
CLINICAL CANCER RESEARCH (2017)
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
Andrew S. Venteicher et al.
SCIENCE (2017)
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
Sean P. Arlauckas et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Paulo C. Rodriguez et al.
FRONTIERS IN IMMUNOLOGY (2017)
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
Susanne M. Steggerda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas
Anna Gieryng et al.
SCIENTIFIC REPORTS (2017)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression
A. Ellert-Miklaszewska et al.
ONCOGENE (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages
Ian Zhang et al.
PLOS ONE (2016)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
The immune checkpoint inhibitors: where are we now?
Rachel Webster
NATURE REVIEWS DRUG DISCOVERY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jerome Galon et al.
IMMUNITY (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Rational combinations of immunotherapeutics that target discrete pathways
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis
Jing Zhang et al.
CARCINOGENESIS (2012)
Altered functions of natural killer cells in response to L-Arginine availability
Bruno Lamas et al.
CELLULAR IMMUNOLOGY (2012)
Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
Patrick Raber et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages
Daniel Baitsch et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R
Hanbo Chen et al.
BMC BIOINFORMATICS (2011)
Characteristics of the Alternative Phenotype of Microglia/Macrophages and its Modulation in Experimental Gliomas
Konrad Gabrusiewicz et al.
PLOS ONE (2011)
Recent advances in arginine metabolism: roles and regulation of the arginases
Sidney M. Morris
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion
D. S. Markovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Bo Huang et al.
CANCER LETTERS (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Suppression of T-cell functions by human granulocyte arginase
Markus Munder et al.
BLOOD (2006)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Session I: Basic aspects of arginine metabolism - Discussion summary
SM Morris
JOURNAL OF NUTRITION (2004)
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas
M Platten et al.
ANNALS OF NEUROLOGY (2003)
分享论文
